Cosmetic surgery is a unique discipline of medicine focused on
enhancing appearance through surgical and medical techniques. Cosmetic surgery
can be performed on all areas of the head, neck and body. Because treated areas
function properly but lack aesthetic appeal, cosmetic surgery is elective.
The most important thing is that the terms 'plastic surgery' and 'cosmetic
surgery' are not interchangeable. Confusion about the terms has led to public
misconceptions about the two specialties. Cosmetic surgery is the "surgery
of appearance." It is elective and focuses on the aesthetics of beauty.
Explore More Insights@
https://www.alliedmarketresearch.com/request-sample/16865
The development of the worldwide cosmetic surgery market share is
majorly driven by increase in prevalence of cosmetic surgical procedure; rise
in demand for aesthetic procedure; and rise in technological advancement in
healthcare sector. As per American Society of Plastic Surgeon, in 2020, it was
accounted for that around 352,555 rhinoplasty technique are acted in U.S in
2020. It was dissected that the rhinoplasty was the main surgery acted in the
U.S in 2020.
Technological development in the medical device industry to
manufacture advanced cosmetic surgical products is expected to provide
remunerative opportunities for expansion of the global cosmetic surgery market
during the cosmetic surgery market forecast. Moreover, presence of key
manufacturing companies to manufacture cosmetic surgery products and rise in
expenditure on healthcare products propel growth of the market.
Key Market Players
- ·
Abbvie Inc
- ·
Bausch Health Companies Inc.
- ·
Candela Syneron
- ·
cynosure inc
- ·
Galderma SA
- ·
Merz Pharma GmbH and Co. KGaA
- ·
Sientra Inc
- ·
Sinclair Pharmaceuticals Limited
- ·
Teoxane Laboratories
- ·
Johnson and Johnson
According to a new report published by Allied Market Research,
titled, “Cosmetic Surgery Market," The cosmetic surgery market size
was valued at $67.3 billion in 2021, and is estimated to reach $201.0 billion
by 2031, growing at a CAGR of 11.6% from 2022 to 2031.
North America accounted for a majority of the global cosmetic
surgery market share in 2021, and is anticipated to remain dominant during the
forecast period. This is attributed to rise in number of breast augmentation
procedures, increase in number of approvals for cosmetic surgery products,
presence of cosmetic surgery industry, and advancements in healthcare, medical devices,
and aesthetic sector in the region. Asia-Pacific is anticipated to witness
lucrative growth, owing to increase in number of liposuctions, rise in
awareness among young population regarding aesthetics, growth in health care
expenditures, and rise in adoption of aesthetic products.
0 Comments